Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


50 firms object Greece's new medicine prices

This article was originally published in Scrip

Executive Summary

Pharmaceutical firms are not happy with the way the Greek government is cutting €1.2 billion off its drugs bill as part of a wider fiscal crisis. Some 50 of the 200-odd firms in the country are objecting to the drug prices spelled out in the price bulletin that was published earlier this month. Scrip had learnt the figure from the ministry of economy, competitiveness and shipping.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts